Pomerantz Investigates NuScale After UBS Downgrade
Analysis based on 7 articles · First reported Sep 17, 2026 · Last updated Sep 22, 2026
The investigation adds legal and reputational pressure on NuScale after an already sharp share-price decline, keeping negative sentiment on the stock and raising the risk of further volatility or a securities class action. For the broader market, the impact is limited to the nuclear and small modular reactor sector, where the downgrade and probe may weigh on peers' valuations and investor confidence.
Pomerantz LLP announced it is investigating claims on behalf of investors of NuScale Power regarding whether NuScale and certain of its officers and/or directors engaged in securities fraud or other unlawful business practices. The investigation follows a September 11, 2026 UBS downgrade of NuScale from Neutral to Sell, with a price target cut from $10 to $6. UBS analyst Jon Windham reportedly stated that NuScale is rapidly losing its first-mover advantage in small modular reactor technology to faster-moving competitors, and flagged a five-year build timeline, a lack of firm customer commitments, and projected $700 million in negative free cash flow between 2026 and 2028. The UBS report also described stagnating progress on NuScale's key RoPower project in Romania and its partnership with the United States — Tennessee Valley Authority. On the downgrade news, NuScale shares fell $1.60, or 15.67%, to close at $8.61 on September 11, 2026. Pomerantz is soliciting affected investors to contact Danielle Peyton to join a potential class action. The investigation is at a preliminary stage and no lawsuit has been filed.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard